About Craig Crews
Craig Crews filed with the SEC as 10% owner of Arvinas in 2018.
Form D filings name Craig Crews as a co-founder & scientific advisor, quarry thera, director at Quarry Thera and Quarry Thera, a director at Duracrin and an officer and a, director at Quarry Thera.
Craig Crews reports to the SEC as a major shareholder of 1 public company.
Craig Crews first appears on SEC filings in 2018.
Experience
This experience comes from Craig Crews's profile and from SEC filings. For roles taken from filings, the years are when the filings name Craig Crews in the role, so the role may have started earlier or lasted longer.
AI
Arvinas, Inc. Current
10% owner
Founder (2013 – Present)
2013 – Present · Public company (ARVN)
YD
Yale Center for Molecular Discovery Current
Executive Director
2003 – Present
YU
Yale University Current
John C. Malone Professor of Mol., Cellular, and Developmental Biology; Chemistry; Pharmacology
1995 – Present
Quarry Heme, Inc
Co-Founder & Scientific Advisor, Quarry Thera, director
2026 · New Haven, CT
Develops small-molecule medicines for immune system diseases.
Quarry DAC, Inc
Co-Founder & Scientific Advisor, Quarry Thera, director
2026 · New Haven, CT
Develops proximity-based therapies.
HT
Halda Therapeutics
Founder
2019 – 2026
PR
Proteolix
Co-Founder
2003 – 2009
Key Colleagues at Startups
The people Craig Crews works with at each company, as listed on that company's latest Form D.
Quarry Heme, Inc · Form D, Feb 25, 2026
SC
Sean Cassidy
President and director
Quarry DAC, Inc · Form D, Feb 25, 2026
SC
Sean Cassidy
President and director
Duracrin, LLC · Form D, Feb 25, 2026
SC
Sean Cassidy
Chief Financial Officer and director
Quarry Thera, LLC · Form D, Feb 21, 2025
DM
Dan McHugh
Director
MD
Mikael Dolsten
Director